Home
/
Fulcrum Therapeutics, Inc.
/
Financials
/
Quarterly
Fulcrum Therapeutics, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Fulcrum Therapeutics, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2022
Sep 30, 2021
$7.80M
Nov 8, 2022
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($19.60M)
Oct 29, 2025
Q3
2025
Jun 30, 2025
($17.30M)
Oct 29, 2025
Q2
2025
Jun 30, 2025
($17.30M)
Jul 29, 2025
Q3
2025
Mar 31, 2025
($17.66M)
Oct 29, 2025
Q1
2025
Mar 31, 2025
($17.66M)
May 1, 2025
Q2
2025
Mar 31, 2025
($17.66M)
Jul 29, 2025
Q3
2025
Sep 30, 2024
($21.70M)
Oct 29, 2025
Q2
2025
Jun 30, 2024
$55.41M
Jul 29, 2025
Q3
2025
Jun 30, 2024
$55.41M
Oct 29, 2025
Q3
2025
Mar 31, 2024
($26.87M)
Oct 29, 2025
Q1
2025
Mar 31, 2024
($26.87M)
May 1, 2025
Q2
2025
Mar 31, 2024
($26.87M)
Jul 29, 2025
Q3
2024
Sep 30, 2023
($24.02M)
Nov 13, 2024
Q3
2024
Jun 30, 2023
($23.78M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($23.78M)
Jul 31, 2024
Q1
2023
Jun 30, 2023
($23.78M)
Aug 3, 2023
Q3
2024
Mar 31, 2023
($24.78M)
Nov 13, 2024
Q1
2024
Mar 31, 2023
($24.78M)
May 13, 2024
Q2
2024
Mar 31, 2023
($24.78M)
Jul 31, 2024
Q3
2023
Sep 30, 2022
($23.74M)
Nov 7, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($21.86M)
Oct 29, 2025
Q2
2025
Jun 30, 2025
($19.82M)
Jul 29, 2025
Q1
2025
Mar 31, 2025
($20.40M)
May 1, 2025
Q3
2025
Sep 30, 2024
($25.13M)
Oct 29, 2025
Q2
2025
Jun 30, 2024
$52.49M
Jul 29, 2025
Q1
2025
Mar 31, 2024
($29.83M)
May 1, 2025
Q3
2024
Sep 30, 2023
($27.44M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($27.29M)
Jul 31, 2024
Q1
2023
Jun 30, 2023
($27.29M)
Aug 3, 2023
Q1
2024
Mar 31, 2023
($27.94M)
May 13, 2024
Q3
2023
Sep 30, 2022
($24.36M)
Nov 7, 2023
Q2
2022
Jun 30, 2022
($34.24M)
Aug 11, 2022
Q1
2023
Jun 30, 2022
($34.24M)
Aug 3, 2023
Q1
2023
Mar 31, 2022
($26.00M)
May 15, 2023
Q3
2022
Sep 30, 2021
($20.77M)
Nov 8, 2022
Q2
2022
Jun 30, 2021
($19.68M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($17.04M)
May 9, 2022
Q3
2021
Sep 30, 2020
($19.10M)
Nov 4, 2021
Q2
2021
Jun 30, 2020
($15.92M)
Aug 10, 2021
Q1
2021
Mar 31, 2020
($18.80M)
May 6, 2021